Publications by authors named "Sergey P Dementev"
Curr Rheumatol Rev
July 2024
Article Synopsis
- Ankylosing spondylitis (AS) is a chronic inflammatory disease affecting the spine, and adalimumab, a TNF inhibitor, shows promise as a treatment option.
- A systematic review analyzed 14 randomized controlled trials with 4,500 participants, comparing adalimumab to placebo and other treatments.
- Results indicate that adalimumab effectively reduces disease activity and improves physical function without a significant increase in adverse effects, highlighting the need for further studies on its long-term efficacy and safety.
